Published in Eur J Clin Pharmacol on May 28, 2008
Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine. Cancer Discov (2014) 1.59
Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol (2011) 1.29
Why can't we find a new treatment for SLE? J Autoimmun (2009) 1.15
Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective. Indian J Med Res (2014) 0.96
Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD. J Crohns Colitis (2010) 0.92
Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol (2013) 0.88
Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia. BMC Cancer (2014) 0.84
Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism. Oncologist (2011) 0.83
Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther (2009) 0.83
Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population. Eur J Clin Pharmacol (2010) 0.82
Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study. Dig Dis Sci (2016) 0.81
Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol (2008) 0.81
Monitoring and safety of azathioprine therapy in inflammatory bowel disease. Pediatr Gastroenterol Hepatol Nutr (2013) 0.81
Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol (2014) 0.81
Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia. Med Oncol (2013) 0.81
"Personalizing" academic medicine: opportunities and challenges in implementing genomic profiling. Transl Res (2009) 0.81
Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. World J Gastroenterol (2009) 0.80
Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population. Eur J Clin Pharmacol (2008) 0.80
A New View into the Regulation of Purine Metabolism: The Purinosome. Trends Biochem Sci (2016) 0.79
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther (2016) 0.79
High-resolution melting analysis of the TPMT gene: a study in the Polish population. Genet Test Mol Biomarkers (2012) 0.78
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro. Cell Biol Toxicol (2015) 0.78
Thiopurine S-methyltransferase (TPMT) activity is better determined by biochemical assay versus genotyping in the Jewish population. Dig Dis Sci (2014) 0.77
Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease. Ann Gastroenterol (2012) 0.77
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver (2016) 0.77
Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity-A Retrospective Study. Can J Gastroenterol Hepatol (2016) 0.75
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy. Oncotarget (2017) 0.75
Safety of azathioprine use during pregnancy. Can Fam Physician (2011) 0.75
A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs. Mol Diagn Ther (2016) 0.75
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Clin Mol Hepatol (2016) 0.75
A disease spectrum for ITPA variation: advances in biochemical and clinical research. J Biomed Sci (2016) 0.75
Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme. Curr Med Chem (2016) 0.75
Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric Microbes. Front Microbiol (2017) 0.75
Managing refractory Crohn's disease: challenges and solutions. Clin Exp Gastroenterol (2015) 0.75
Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases. Clin Rheumatol (2017) 0.75
Monitoring thiopurine metabolites in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75
Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology (2001) 4.28
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med (1997) 4.13
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet (1980) 3.71
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst (1999) 3.58
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet (1990) 3.38
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology (2000) 2.99
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest (2003) 2.97
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med (1995) 2.95
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med (1989) 2.70
The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol (1992) 2.53
The purine path to chemotherapy. Science (1989) 2.47
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc (1967) 2.44
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology (2002) 2.35
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics (2004) 2.32
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol (1997) 2.28
Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J Pediatr (1991) 2.24
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol (1989) 2.24
Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol (1999) 2.21
A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch Biochem Biophys (1972) 2.16
Management of Crohn's disease in adults. Am J Gastroenterol (2001) 2.09
Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science (1996) 2.05
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics (2004) 2.04
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet (2002) 2.03
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut (1993) 2.01
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82
Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta (1978) 1.81
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology (2002) 1.80
Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology (1999) 1.78
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics (1999) 1.76
Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J (Clin Res Ed) (1982) 1.75
Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet (1996) 1.73
Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet (2007) 1.66
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer (1976) 1.64
The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med J Aust (1962) 1.64
Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol (2002) 1.60
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther (1997) 1.56
Warfarin and azathioprine: an important drug interaction. Am J Med (1992) 1.55
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther (1994) 1.51
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics (1996) 1.50
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia (2000) 1.48
Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol (2000) 1.46
Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos (2001) 1.45
Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet (1999) 1.40
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A (1995) 1.36
Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.32
The fate of 6-mercaptopurine in man. Ann N Y Acad Sci (1954) 1.30
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 1.29
Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy? Ann Clin Biochem (2004) 1.27
Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci U S A (1997) 1.23
Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol (1995) 1.23
The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease. Am J Gastroenterol (1994) 1.20
Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther Drug Monit (2004) 1.19
Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet (1999) 1.19
Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics (1999) 1.18
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol (1996) 1.16
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology (1998) 1.14
Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotides. Biochem Pharmacol (1969) 1.13
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut (2001) 1.11
Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. Pharmacogenetics (1999) 1.11
Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 1.11
Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol. Cancer (1979) 1.10
Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction. Clin Pharmacol Ther (1997) 1.10
RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES. Cancer Res (1963) 1.08
The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics. Pharmacogenomics (2002) 1.08
Human kidney thiopurine methyltransferase. Purification and biochemical properties. Biochem Pharmacol (1983) 1.07
Distribution of ITPA P32T alleles in multiple world populations. J Hum Genet (2004) 1.07
Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol (2003) 1.05
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics (2002) 1.01
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther (1983) 1.00
Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives. Mol Pharmacol (1983) 1.00
Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics (2001) 0.99
Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Arch Intern Med (1991) 0.95
Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin Chem (2003) 0.95
Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol (2006) 0.95
Azathioprine therapy for patients with systemic lupus erythematosus. Lupus (2001) 0.94
Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol (2001) 0.93
The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation (1992) 0.93
Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis. Clin Pharmacol Ther (2000) 0.93
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics (2004) 0.92
Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol (2004) 0.92
Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine. Cancer Chemother Pharmacol (1998) 0.92
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood (1984) 0.91
Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat (1998) 0.91
Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. J Clin Invest (1998) 0.91
Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines. J Pharmacol Exp Ther (2004) 0.90
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942). Pediatr Blood Cancer (2007) 0.89
Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther (1992) 0.89
Diminished anticoagulant effects of warfarin with concomitant mercaptopurine therapy. Pharmacotherapy (2003) 0.88
Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Pharm Res (1999) 0.87
Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans. Clin Pharmacol Ther (1998) 0.86
Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol (1990) 0.85
Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics (2004) 0.85
Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int (1996) 0.85
Drug interaction between infliximab and azathioprine in patients with Crohn's disease. Aliment Pharmacol Ther (2003) 0.85
Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol (2004) 0.85
Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30
Sleep as a fundamental property of neuronal assemblies. Nat Rev Neurosci (2008) 2.79
A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination. PLoS One (2007) 1.12
Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother (2009) 0.93
Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody. Clin Pharmacokinet (2012) 0.90
Solar photothermochemical reaction and supercritical CO2 work up for a fully green process of preparation of pure p-nitrobenzyl bromide. Environ Sci Technol (2013) 0.75